Evidence map›Paper›PMID 35116442›Full record

ArticleTranslational cancer research2021

A rare multiple primary sarcomatoid carcinoma (SCA) of small intestine harboring driver gene mutations: a case report and a literature review.

Zhu Zhu, Xinyi Liu, Wenliang Li, Zhengqi Wen, Xiang Ji, Ruize Zhou, Xiaoyu Tuo, Yaru Chen, Xian Gong, Guifeng Liu and 4 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Translational cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Jejunal sarcomatoid carcinoma: A case report and review of literature.World journal of gastrointestinal oncology · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Zhu Zhu *Department of Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Xinyi Liu *HaploX Biotechnology, Shenzhen, China.
Wenliang LiDepartment of Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Zhengqi WenDepartment of Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Xiang JiDepartment of Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Ruize ZhouDepartment of Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Xiaoyu TuoDepartment of Pathology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Yaru ChenHaploX Biotechnology, Shenzhen, China.
Xian GongHaploX Biotechnology, Shenzhen, China.
Guifeng LiuHaploX Biotechnology, Shenzhen, China.
Yanqing ZhouHaploX Biotechnology, Shenzhen, China.
Shifu ChenHaploX Biotechnology, Shenzhen, China.
Lele Song *HaploX Biotechnology, Shenzhen, China.
Jian HuangDepartment of Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Shenzhen Bioeasy Biotechnology (China) · CNKunming Medical University · CNFirst Affiliated Hospital of Kunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary sarcomatoid carcinoma (SCA) is a type of rare tumor consisting of both malignant epithelial and mesenchymal components. Only 32 cases of SCA of the small bowel have been reported in the literature to date. Due to its rarity and complexity, this cancer has not been genetically studied and its diagnosis and treatment remain difficult. Here we report a 54-year-old male underwent emergency surgical resection in the small intestine due to severe obstruction and was diagnosed with multiple SCA based on postoperative pathological examination. Over 100 polypoid tumors scattered along his whole jejunum and proximal ileum. Chemotherapy (IFO+Epirubicin) was performed after surgery while the patient died two months after the surgery due to severe malnutrition. Whole-exome sequencing was performed for the tumor tissue with normal tissue as the control. Important cancer-related gene mutations, including KRAS (c.37G>T, p.G13C), TP53 (c.871A>T, p.K291*), EGFR (c.1351C>T, p.R451C), and CDKN2A (c.104_138del, p.G35fs), were found among 286 nonsynonymous somatic mutations (SNV and Indel). Copy-number amplified genes mainly gathered in chromosome 6, 7, 16 and 20. Mutation clustering analysis showed that main genetic abnormalities included DNA methylation, DNA alkylation, cellular homeostasis, and shared similarities with melanoma, glioma, prostate cancer, bladder cancer, non-small cell lung cancer, and pancreatic cancer. In summary, the genomic features of the small intestine SCA were explored at whole-exome level for the first time, and over 200 somatic mutations were identified in the tumor tissue. Key tumor driver gene mutations were revealed, as well as several aberrant functional pathways. These results contribute to further understanding of the pathogenesis and molecular mechanism of this rare tumor.

Indexed as

case reportKRASSarcomatoid carcinoma (SCA)small intestineTP53

Identifiers

PMID35116442
PMCPMC8798874
OpenAlexW3134230605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.